Trademark Overview
On Wednesday, March 8, 2023, a trademark application was filed for THERAPLAS with the United States Patent and Trademark Office. The USPTO has given the THERAPLAS trademark a serial number of 97828627. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, March 13, 2024. This trademark is owned by Imunon, Inc.. The THERAPLAS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
